EW — Edwards Lifesciences Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1099800 ·
Last close
$93.05
Market Cap
$53.58B
52W High
$96.29
52W Low
$78.29
ADV30
4,664,306
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 1,569,600,000 | 1,226,600,000 | 370,300,000 | 91,200,000 | 13,697,200,000 | 2,938,000,000 | 3,359,600,000 |
| Sep 2025 | 1,553,100,000 | 1,207,900,000 | 425,100,000 | 291,100,000 | 13,272,200,000 | 2,685,600,000 | 3,067,200,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,358,600,000
Investing CF
$-891,000,000
Financing CF
$-1,150,000,000
CapEx
$-269,100,000
Dividends Paid
—
Buybacks
$-1,056,600,000
EPS Diluted TTM
$1.74
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$14,621,200,000
Inventory
$1,119,000,000
Receivables
$973,000,000
ST Investments
$1,226,000,000
EBIT TTM
$1,398,100,000
Pretax Income TTM
$1,298,000,000
Interest Exp TTM
—
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,512,300,032
EBITDA
$1,996,800,000
Free Cash Flow
$1,232,412,544
Enterprise Value
$50,192,621,568
Total Cash
$4,252,699,904
Total Debt
$704,400,000
Shares Out
575,800,000
Trailing EPS
$1.67
Book Value
$18.41
ROE
9.2%
ROA
8.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,067,600,000 | 1,636,200,000 | 1,073,500,000 | 13,697,200,000 | 3,359,600,000 | — | 1,595,200,000 |
| Dec 2024 | 5,439,500,000 | 1,480,100,000 | 4,174,600,000 | 13,055,300,000 | 2,992,400,000 | — | 542,300,000 |
| Dec 2023 | 5,010,000,000 | 1,486,200,000 | 1,402,400,000 | 9,363,200,000 | 2,643,800,000 | — | 895,800,000 |
| Dec 2022 | 4,464,000,000 | 1,539,100,000 | 1,521,900,000 | 8,292,500,000 | 2,485,800,000 | — | 1,218,200,000 |
TTM Snapshot
Revenues TTM
$5,227,000,000
NetIncome TTM
$4,139,300,000
OpCashFlow TTM
$0
Assets (Latest)
$13,055,300,000
Forward EPS
$3.38
Max Pain — expiry 2026-08-21
max pain strike: $85.00 · spot: $92.56 · call oi: 8,263 · put oi: 10,234
Expected Move to 2026-08-21:
±$2.77
(3.00%) —
implied range
$89.78 –
$95.33
· ATM straddle on $92.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BDX | BECTON DICKINSON & CO | $50.00B | $183.58 | — |
| BSX | BOSTON SCIENTIFIC CORP | $74.52B | $51.42 | — |
| DXCM | DEXCOM INC | $34.26B | $90.80 | — |
| GEHC | GE HealthCare Technologies Inc. | $32.88B | $72.28 | — |
| RMD | RESMED INC | $32.78B | $226.00 | — |
News headlines (Yahoo Finance, 1h cache)
Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation
2026-08-13 12:51 · Yahoo
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?
2026-08-12 13:01 · Yahoo
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match
2026-08-04 15:17 · Yahoo
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
2026-07-27 20:20 · Yahoo
Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium
2026-07-25 05:11 · Yahoo
Edwards, The 'Cleanest Large-Cap Medtech Story,' Reverses After Quarterly Beat
2026-07-24 20:19 · Yahoo
Edwards lifts FY26 growth outlook following steady Q2 performance
2026-07-24 13:18 · Yahoo
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion
2026-07-24 11:26 · Yahoo
Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ...
2026-07-24 05:00 · Yahoo
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary
2026-07-24 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.